Structure of 9-amino-[N-(2-dimethylamino)propyl]acridine-4-carboxamide bound to d(CGTACG)2:: a comparison of structures of d(CGTACG)2 complexed with intercalators in the presence of cobalt

被引:11
作者
Adams, A [1 ]
Guss, JM
Denny, WA
Wakelin, LPG
机构
[1] Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia
[2] Univ Auckland, Fac Med & Hlth Sci, Auckland Canc Soc Res Ctr, Auckland 1, New Zealand
[3] Univ New S Wales, Sch Med Sci, Sydney, NSW 2052, Australia
来源
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY | 2004年 / 60卷
关键词
D O I
10.1107/S0907444904003907
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The structure of the complex formed between 9-amino-[N-(2-dimethylamino)propyl]acridine-4-carboxamide and d(CGTACG)(2) has been refined to a resolution of 1.55 Angstrom. The complex crystallized in space group C222. An asymmetric unit comprises two strands of DNA, one disordered drug molecule, two cobalt(II) ions, two magnesium ions and 32 water molecules The DNA helices stack in continuous. columns, with their four central base pairs adopting a B-like motif. The terminal G-C base pairs engage in different interactions. At one end of the duplex there is a CpG dinucleotide overlap modified by ligand intercalation and terminal cytosine exchange between symmetry-related duplexes. An intercalation complex is formed involving four DNA duplexes, four disordered ligand molecules and two pairs of base tetrads. The other end of the DNA is frayed, with the terminal guanine lying in the minor groove of the next duplex in the column. The structure is stabilized by guanine N7-cobalt(II) coordination. The structure is compared with previously published isomorphous structures of d(CGTACG)(2) complexed with intercalators in the presence of cobalt and it is concluded that the formation of this crystal form is primarily determined by DNA-DNA interactions and packing forces, rather than by special interactions between the ligand and the DNA. Given the nature of the ligands found in these complexes, the relevance of the quadruplex structure to the biological activity of those agents, known to be topoisomerase poisons, is questioned.
引用
收藏
页码:823 / 828
页数:6
相关论文
共 26 条
[1]   A novel form of intercalation involving four DNA duplexes in an acridine-4-carboxamide complex of d(CGTACG)2 [J].
Adams, A ;
Guss, JM ;
Collyer, CA ;
Denny, WA ;
Wakelin, LPG .
NUCLEIC ACIDS RESEARCH, 2000, 28 (21) :4244-4253
[2]   Acridinecarboxamide topoisomerase poisons:: Structural and kinetic studies of the DNA complexes of 5-substituted 9-amino-(N-(2-dimethylamino)ethyl)acridine-4-carboxamides [J].
Adams, A ;
Guss, JM ;
Collyer, CA ;
Denny, WA ;
Prakash, AS ;
Wakelin, LPG .
MOLECULAR PHARMACOLOGY, 2000, 58 (03) :649-658
[3]   Crystal structure of 9-amino-N-[2-(4-morpholinyl)ethyl]-4-acridinecarboxamide bound to d(CGTACG)2:: implications for structure-activity relationships of acridinecarboxamide topoisomerase poisons [J].
Adams, A ;
Guss, JM ;
Denny, WA ;
Wakelin, LPG .
NUCLEIC ACIDS RESEARCH, 2002, 30 (03) :719-725
[4]   Crystal structure of the topoisomerase II poison 9-amino-[N-(2-dimethylamino)ethyl]acridine-4-carboxamide bound to the DNA hexanucleotide d(CGTACG)2 [J].
Adams, A ;
Guss, JM ;
Collyer, CA ;
Denny, WA ;
Wakelin, LPG .
BIOCHEMISTRY, 1999, 38 (29) :9221-9233
[5]  
[Anonymous], SHELX97 MANUAL
[6]   POTENTIAL ANTITUMOR AGENTS .43. SYNTHESIS AND BIOLOGICAL-ACTIVITY OF DIBASIC 9-AMINOACRIDINE-4-CARBOXAMIDES, A NEW CLASS OF ANTITUMOR AGENT [J].
ATWELL, GJ ;
CAIN, BF ;
BAGULEY, BC ;
FINLAY, GJ ;
DENNY, WA .
JOURNAL OF MEDICINAL CHEMISTRY, 1984, 27 (11) :1481-1485
[7]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[8]   THE NUCLEIC-ACID DATABASE - A COMPREHENSIVE RELATIONAL DATABASE OF 3-DIMENSIONAL STRUCTURES OF NUCLEIC-ACIDS [J].
BERMAN, HM ;
OLSON, WK ;
BEVERIDGE, DL ;
WESTBROOK, J ;
GELBIN, A ;
DEMENY, T ;
HSIEH, SH ;
SRINIVASAN, AR ;
SCHNEIDER, B .
BIOPHYSICAL JOURNAL, 1992, 63 (03) :751-759
[9]  
Denny W A, 1997, Expert Opin Investig Drugs, V6, P1845, DOI 10.1517/13543784.6.12.1845
[10]  
DENNY WA, 1986, ANTI-CANCER DRUG DES, V1, P141